SCHEMBL1083010

SCHEMBL1083010

CCC(C(=O)O)n1nc(C(C)(C)C)cc1NC(=O)Nc1cccc(Oc2ncnc3cc(OC)c(OC)cc23)c1

nearest known ligand 0.83

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.83
RAF1 P04049 8/20 0.83

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015498 0.91 BRAF (1.00) BRAFRAF1
SCHEMBL19473588 0.88 BRAF (0.84) BRAFRAF1
SCHEMBL1012469 0.88 BRAF (1.00) BRAFRAF1
SCHEMBL2640218 0.86 BRAF (0.84) BRAFRAF1
SCHEMBL1014995 0.86 BRAF (1.00) BRAFRAF1
SCHEMBL1013891 0.85 BRAF (1.00) BRAFRAF1
SCHEMBL1013344 0.85 BRAF (1.00) BRAFRAF1
SCHEMBL1013459 0.85 BRAF (1.00) BRAFRAF1
SCHEMBL1011744 0.85 BRAF (1.00) BRAFRAF1
SCHEMBL1083013 0.84 BRAF (1.00) BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268623-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2011-01-05 EP disclosed
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 WO disclosed